Global Breast Cancer Brachytherapy Market Size & Outlook

The breast cancer brachytherapy industry worldwide is expected to reach a projected revenue of US$ 105.3 million by 2027. A compound annual growth rate of 6.8% is expected of the worldwide breast cancer brachytherapy industry from 2019 to 2027.

Revenue, 2018 (US$M)
$58.4
Forecast, 2027 (US$M)
$105.3
CAGR, 2019 - 2027
6.8%
Report Coverage
Worldwide

Global breast cancer brachytherapy market highlights

  • The global breast cancer brachytherapy market generated a revenue of USD 58.4 million in 2018 and is expected to reach USD 105.3 million by 2027.
  • The market is expected to grow at a CAGR (2019 - 2027) of 6.8% by 2027.
  • In terms of segment, high dose rate (hdr) accounted for a revenue of USD 38.7 million in 2018.
  • High Dose Rate (HDR) is the most lucrative technology segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2018.
  • Country-wise, U.S. is expected to register the highest CAGR from 2019 to 2027.

Global data book summary

Market revenue in 2018USD 58.4 million
Market revenue in 2027USD 105.3 million
Growth rate6.8% (CAGR from 2018 to 2027)
Largest segmentHigh dose rate (hdr)
Fastest growing segmentHigh Dose Rate (HDR)
Historical data covered2015 - 2017
Base year for estimation2018
Forecast period covered2019 - 2027
Quantitative unitsRevenue in USD million
Market segmentationHigh Dose Rate (HDR), Low Dose Rate (LDR)

Other key industry trends

  • In terms of revenue, the North America accounted for 50.7% of the global breast cancer brachytherapy market in 2018.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2027.
  • By country, U.S. is the fastest growing regional market and is projected to reach USD 44.4 million by 2027.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Breast Cancer Brachytherapy Market Companies

Name Profile # Employees HQ Website

Global breast cancer brachytherapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer brachytherapy market will help companies and investors design strategic landscapes.


high dose rate (hdr) was the largest segment with a revenue share of 66.27% in 2018. Horizon Databook has segmented the Global breast cancer brachytherapy market based on high dose rate (hdr), low dose rate (ldr) covering the revenue growth of each sub-segment from 2015 to 2027.


  • Global Breast Cancer Brachytherapy Technology Outlook (Revenue, USD Million, 2015-2027)
    • High Dose Rate (HDR)
    • Low Dose Rate (LDR)

Reasons to subscribe to Global breast cancer brachytherapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global breast cancer brachytherapy market databook

  • Our clientele includes a mix of breast cancer brachytherapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global breast cancer brachytherapy market, including forecasts for subscribers. This global databook contains high-level insights into Global breast cancer brachytherapy market from 2015 to 2027, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global breast cancer brachytherapy market statistics, by regions, 2015-2027 (US$M)

Top 10 countries: Breast cancer brachytherapy market size, 2018 (USD Million)

Top 10 countries: Breast cancer brachytherapy market size, 2018 (USD Million)

Global breast cancer brachytherapy market, by region, 2018 (US$M)

Global breast cancer brachytherapy market statistics, by regions, 2015-2027 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more